Sector: MedicalMGI PHARMA, Inc. (NASDAQ: MOGN)
Ranking History
Scan Date: | 11/17/2009 |
Sector: | Medical |
Funamental : | 12 |
Technical : | 176 |
Performance : | 187 |
Overall: | 108 |
Number of Stocks: | 307 |
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 12 |
Technical : | 136 |
Performance : | 190 |
Overall: | 84 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 16 |
Technical : | 115 |
Performance : | 192 |
Overall: | 75 |
Number of Stocks: | 306 |
Headlines
- A New Index of Health Product Innovators
Jan 04, 2009 09:08 PM | AMGN, CEPH, CVTX, ESALY, MGI, MOGN
- Best Performing Stocks the past Month
Dec 24, 2007 01:34 PM | AAP, AAPL, ACI, ADM, AGO, AGU
- Regeneron Initiates Major Global Collaboration with Sanofi-aventis to Develop and Commercialize Fully-Human Therapeutic Antibodies and Published Data Suggest That ERBITUX(R) Enables Complete Surgical Resection of Colorectal Liver Metastases in Patients Previously Refractory to Conventional Systemic Therapy
Nov 30, 2007 09:28 AM | IMCL, MOGN, REGN
- For Biotechs, Waiting Until All Data Are In Has Its Rewards
Sep 24, 2007 12:54 PM | ACOR, IMCL, MOGN, MRK, ONXX, PHRM
- Companies Reporting After Close (07/18/2007)- Part 2
Jul 18, 2007 10:15 AM | JCI, JNPR, KNL, KNX, LHO, LOGI
- NASDAQ Technical Picture - Consolidation Day - Jul 17 2007 1:32AM
Jul 17, 2007 01:32 AM | ABT, ALDN, AMD, AMFI, AVCT, BAC
- MethylGene Updates Development Plans
Dec 15, 2006 08:04 AM | MOGN
- MethylGene Updates Development Plans
Dec 15, 2006 08:04 AM | MOGN
- GlaxoSmithKline and Adolor Report Top-Line Results From Phase 3 Studies of Alvimopan and Abbott's XIENCE V(TM) Drug-Eluting Coronary Stent Superior to TAXUS(R) Stent
Sep 06, 2006 02:20 PM | ABT, GSK, MOGN
- Genstruct Extends Collaboration in Cancer with GlaxoSmithKline and MGI PHARMA Announces Executive Appointments
Aug 14, 2006 12:50 PM | AVII, GSK, MOGN
- Gliadel(R) Wafer Clinical Data Presented at Society for Neuro-Oncology Meeting
Nov 20, 2006 07:01 AM | MOGN
- (OTCBB: PLBI) Proton Laboratories Completes New Funding
Jul 20, 2006 07:00 AM | CTXS, MOGN, OPWV
- U.S. FDA Approves Dacogen(TM) (Decitabine) For Injection
May 03, 2006 07:01 AM | MOGN, SUPG
- Dacogen(TM) (Decitabine) Injection Complete Response Accepted for Review by U.S. FDA
Dec 15, 2005 04:38 PM | MOGN, SUPG
- Dacogen(TM) (Decitabine) Injection Data Presented at American Society of Hematology (ASH) Annual Meeting
Dec 12, 2005 09:35 AM | MOGN, SUPG
- MGI PHARMA and SuperGen Provide Regulatory Status Updates for Dacogen(TM) (decitabine) Injection for MDS
Nov 15, 2005 09:29 AM | MOGN, SUPG
- Guilford Pharmaceuticals Stockholders Vote to Approve MGI PHARMA Merger
Sep 29, 2005 05:28 PM | MOGN
- Leerink Swann & Company Initiates Coverage of MGI PHARMA, INC. (NASDAQ: MOGN)
Jun 24, 2005 11:46 AM | MOGN
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
MOGN
|
Compare to S&P
|
| YTD |
-0.01 %
|
11.60 %
|
| 4 Weeks |
-0.01 %
|
-0.01 %
|
| 12 Weeks |
-0.01 %
|
-0.01 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 180.00 %
|
|
EPS Growth in Last Year: 250.00 %
|
|
Sales Growth in Last Quarter: 20.93 %
|
|
Sales Growth in Last Quarter: 16.00 %
|
|
